RTW Biotech Opportunities (LON:RTW – Get Free Report)’s share price was down 0.7% on Wednesday . The stock traded as low as GBX 1.47 ($0.02) and last traded at GBX 1.47 ($0.02). 98,745 shares traded hands during trading, a decline of 80% from the average daily volume of 504,050 shares. The stock had previously closed at GBX 1.48 ($0.02).
RTW Biotech Opportunities Stock Performance
The stock has a market cap of £4.93 million, a P/E ratio of 4.08 and a beta of 0.60. The business’s 50-day moving average price is GBX 1.53 and its 200-day moving average price is GBX 1.52.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- EV Stocks and How to Profit from Them
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Stocks to Consider Buying in October
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
